Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rita Alloway

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
JAMA Surgery|February 3, 2021
Early Corticosteroid Cessation vs Long-term Corticosteroid Therapy in Kidney Transplant Recipients: Long-term Outcomes of a Randomized Clinical TrialE Steve Woodle, John S Gill, Stephanie Clark, et al.
Clinical Pharmacokinetics|October 3, 2013
Random-effects linear modeling and sample size tables for two special crossover designs of average bioequivalence studies: the four-period, two-sequence, two-formulation and six-period, three-sequence, three-formulation designsFrancisco J Diaz, Michel J Berg, Ron Krebill, et al.
Annals of Surgery|July 30, 2019
Telemedicine Based Remote Home Monitoring After Liver Transplantation: Results of a Randomized Prospective TrialTiffany C Lee, Tiffany E Kaiser, Rita Alloway, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|June 16, 2020
Plasma cell targeting to prevent antibody-mediated rejectionE Steve Woodle, Simon Tremblay, Amy Rossi, et al.
Progress in Transplantation (Aliso Viejo, Calif.)|October 22, 2004
Evaluation of an immunosuppressant side effect instrumentRebecca P Winsett, Kris Arheart, Robert J Stratta, et al.
Clinical Transplants|June 8, 2010
Bortezomib-based treatment of antibody mediated rejection in pancreas allograft recipientsAmit Govil, R Carlin Walsh, Amit Tevar, et al.
Seminars in Pediatric Surgery|July 5, 2006
Malignancy in pediatric transplant recipientsJoseph F Buell, Thomas G Gross, Mark J Thomas, et al.
Transplantation|July 29, 2003
Donors with central nervous system malignancies: are they truly safe?Joseph F Buell, Jennifer Trofe, Gopalan Sethuraman, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|April 16, 2011
Pharmacokinetics in stable heart transplant recipients after conversion from twice-daily to once-daily tacrolimus formulationsRita Alloway, Johan Vanhaecke, Nizar Yonan, et al.
Transplantation|June 26, 2007
Two years postconversion from a prograf-based regimen to a once-daily tacrolimus extended-release formulation in stable kidney transplant recipientsRita Alloway, Steven Steinberg, Kassem Khalil, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
JAMA Surgery|February 3, 2021
Early Corticosteroid Cessation vs Long-term Corticosteroid Therapy in Kidney Transplant Recipients: Long-term Outcomes of a Randomized Clinical TrialE Steve Woodle, John S Gill, Stephanie Clark, et al.
Clinical Pharmacokinetics|October 3, 2013
Random-effects linear modeling and sample size tables for two special crossover designs of average bioequivalence studies: the four-period, two-sequence, two-formulation and six-period, three-sequence, three-formulation designsFrancisco J Diaz, Michel J Berg, Ron Krebill, et al.
Annals of Surgery|July 30, 2019
Telemedicine Based Remote Home Monitoring After Liver Transplantation: Results of a Randomized Prospective TrialTiffany C Lee, Tiffany E Kaiser, Rita Alloway, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|June 16, 2020
Plasma cell targeting to prevent antibody-mediated rejectionE Steve Woodle, Simon Tremblay, Amy Rossi, et al.
Progress in Transplantation (Aliso Viejo, Calif.)|October 22, 2004
Evaluation of an immunosuppressant side effect instrumentRebecca P Winsett, Kris Arheart, Robert J Stratta, et al.
Clinical Transplants|June 8, 2010
Bortezomib-based treatment of antibody mediated rejection in pancreas allograft recipientsAmit Govil, R Carlin Walsh, Amit Tevar, et al.
Seminars in Pediatric Surgery|July 5, 2006
Malignancy in pediatric transplant recipientsJoseph F Buell, Thomas G Gross, Mark J Thomas, et al.
Transplantation|July 29, 2003
Donors with central nervous system malignancies: are they truly safe?Joseph F Buell, Jennifer Trofe, Gopalan Sethuraman, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|April 16, 2011
Pharmacokinetics in stable heart transplant recipients after conversion from twice-daily to once-daily tacrolimus formulationsRita Alloway, Johan Vanhaecke, Nizar Yonan, et al.
Transplantation|June 26, 2007
Two years postconversion from a prograf-based regimen to a once-daily tacrolimus extended-release formulation in stable kidney transplant recipientsRita Alloway, Steven Steinberg, Kassem Khalil, et al.
Pageof 2